Author:
Oi Akihide,Morishita Katsumi,Awogi Takumi,Ozaki Atsushi,Umezato Masanao,Fujita Shinji,Hosoki Eiji,Morimoto Hajime,Ishiharada Nobuya,Ishiyama Hironobu,Uesugi Tohru,Miyatake Masaya,Senba Tadashi,Shiragiku Toshiyuki,Nakagiri Naoto,Ito Norio
Publisher
Springer Science and Business Media LLC
Subject
Pharmacology (medical),Cardiology and Cardiovascular Medicine,Pharmacology,General Medicine
Reference9 articles.
1. Kondo K, Ogawa H, Yamashita H, et al. 7-Chloro-5hydroxy-1[2-methyl-4-(2-methylbenzoyl-amino)benzoyl]-2,3,4,5-tetrahydro-1H-1-benzazepine (OPC-41061): a potent, orally active nonpeptide arginine vasopressin V2 receptor antagonist. Bioorg Med Chem. 1997;7:1743–54.
2. Yamamura Y, Nakamura S, Itoh S, et al. OPC-41061, a highly potent human vasopressin V2-receptor antagonist: pharmacological profile and aquaretic effect by single and multiple oral dosing in rats. J Pharmacol Exp Ther. 1998;287:860–7.
3. Hirano T, Yamamura Y, Nakamura S, Onogawa T, Mori T. Effects of the V2-receptor antagonist OPC-41061 and the loop diuretic furosemide alone and in combination in rats. J Pharmacol Exp Ther. 2000;292:288–94.
4. Irwin S. Comprehensive observational assessment: Ia. A systematic, quantitative procedure for assessing the behavioral and physiologic state of the mouse. Psychopharmacologia. 1968;13:222–57.
5. Takagi H, Inukai T, Nakama M. A modification of Haffner’s method for testing analgesics. Jpn J Pharmacol. 1966;16:287–94.
Cited by
13 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献